Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.05 EUR | +0.18% | +6.92% | +17.57% |
05:40pm | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... | |
04:39pm | GSK's Application for Jemperli's Expanded Indication Accepted by FDA for Priority Review | MT |
Sales 2024 * | 31.46B 39.12B 36.59B | Sales 2025 * | 33.33B 41.45B 38.77B | Capitalization | 67.46B 83.89B 78.48B |
---|---|---|---|---|---|
Net income 2024 * | 5.66B 7.04B 6.59B | Net income 2025 * | 6.4B 7.96B 7.44B | EV / Sales 2024 * | 2.53 x |
Net Debt 2024 * | 12.17B 15.13B 14.15B | Net Debt 2025 * | 8.93B 11.11B 10.39B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
11.9
x | P/E ratio 2025 * |
10.6
x | Employees | 70,212 |
Yield 2024 * |
3.69% | Yield 2025 * |
3.94% | Free-Float | 92.58% |
Latest transcript on GSK plc
1 day | +0.18% | ||
1 week | +6.92% | ||
Current month | -1.16% | ||
1 month | +0.08% | ||
3 months | +8.38% | ||
6 months | +16.41% | ||
Current year | +17.57% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Urs Rohner
BRD | Director/Board Member | 65 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 19.62 | +3.16% | 647 |
24-04-23 | 19.02 | +1.01% | 278 |
24-04-22 | 18.82 | +2.03% | 116 |
24-04-19 | 18.45 | +1.21% | 271 |
24-04-18 | 18.23 | -0.63% | 276 |
Delayed Quote Deutsche Boerse AG, April 24, 2024 at 09:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.79% | 672B | |
+25.87% | 570B | |
-5.94% | 360B | |
+16.15% | 321B | |
+8.71% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-9.22% | 149B |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock